Welcome to our dedicated page for RAD news (Ticker: RAD), a resource for investors and traders seeking the latest updates and insights on RAD stock.
Rite Aid Corporation (NYSE: RAD) operates at the forefront of integrated retail pharmacy and healthcare services, providing prescription medications, wellness programs, and pharmacy benefit management solutions. This page aggregates all official announcements, financial disclosures, and strategic developments from the company.
Access real-time updates on Rite Aid's operational milestones, including earnings reports, regulatory compliance updates, and partnerships with healthcare providers. Investors will find critical filings like 10-Q and 8-K documents alongside analyses of market positioning against competitors like CVS Health and Walgreens.
The repository covers expansions in telehealth services, PBM contract renewals, and community health initiatives. Content is curated to meet the needs of stakeholders requiring timely, accurate information for decision-making.
Bookmark this page for streamlined tracking of Rite Aid's evolving role in retail healthcare. Check regularly for updates on store network changes, leadership announcements, and responses to industry trends like digital health adoption.
Shipt and Rite Aid have formed a partnership to provide same-day delivery of health and wellness products across 17 states. Customers can order from over 2,000 Rite Aid locations through the Shipt marketplace, with deliveries available in as little as one hour. This collaboration aims to enhance customer experience by offering over 20,000 products for health, beauty, and personal care. To celebrate the launch, a promotional discount of $10 is available for orders over $50 until August 12.
Rite Aid is set to launch its annual fundraising campaign for Children's Miracle Network Hospitals from August 1-28. This ongoing initiative supports 53 local children's hospitals and aims to raise funds for critical healthcare services and research. Over 27 years, Rite Aid has contributed more than $100 million to this cause. Customers can donate during in-store transactions, with all funds remaining local. The campaign highlights the importance of children's hospitals in addressing health challenges faced by future generations.
Rite Aid Corporation (NYSE: RAD) reported a net loss of $13.1 million, or $0.24 loss per share, for Q1 2021, with revenues increasing to $6.16 billion, up 2.2% from the previous year. Adjusted EBITDA reached $138.9 million, or 2.3% of revenues, marking strong performance in the Retail Pharmacy Segment, which saw a 5.5% revenue increase. The company delivered nearly 4.7 million COVID-19 vaccines, enhancing its community role. Looking ahead, total revenues for fiscal 2022 are predicted between $25.1 billion and $25.5 billion, while adjusted net loss per share is expected between $0.79 and $0.24.
Rite Aid (NYSE: RAD) has appointed Andre Persaud as chief retail officer, having previously served as executive vice president, retail since February 2020. Under Persaud's leadership, the company has enhanced in-store experiences and operations aligned with its RxEvolution strategy. CEO Heyward Donigan praised his strategic leadership during challenging times, especially during the COVID-19 pandemic. Persaud has extensive retail experience, managing inventory, supply chain, and developing safety protocols. He holds a pharmacy degree and an MBA from the State University of New York at Buffalo.
Rite Aid Corporation (NYSE: RAD) is set to release its financial results for the Fiscal 2022 First Quarter, ending May 29, 2021, on June 24, 2021. An analyst call will be held at 8:30 a.m. Eastern Time, featuring management remarks, and will be accessible online. A telephone replay will be available from noon on June 24 until July 24, 2021. Rite Aid operates over 2,500 retail pharmacy locations across 17 states, providing healthcare services and products to customers year-round.
Rite Aid (NYSE: RAD) is enhancing vaccine accessibility by extending vaccination hours at over 200 locations during June. This initiative supports the White House and the National Month of Action to increase COVID-19 vaccination rates, aiming for 70% of U.S. adults to receive at least one shot by July 4, 2021. The 'Night Shots' program, starting June 11, includes vaccinations until midnight and 24-hour availability at select locations. Rite Aid has also conducted numerous vaccine clinics to educate communities about vaccine safety.
Rite Aid (NYSE: RAD) announces that it will administer COVID-19 vaccines to individuals 12 years and older, following CDC guidance. Guardians can schedule appointments for those under 18 through Rite Aid's online tool. The company also offers schools and organizations a way to set up on-site vaccine clinics. COO Jim Peters emphasized the importance of accessibility in vaccine distribution. Rite Aid aims to facilitate vaccinations in community settings, aiming to enhance public health engagement through its pharmacy teams.
Rite Aid (NYSE: RAD) has expanded COVID-19 vaccine availability to individuals aged 12 and older at all locations offering the Pfizer vaccine, aligning with CDC guidelines. Appointments can be scheduled online by guardians for those under 18. The company is also facilitating vaccine clinics for schools and organizations, making it easier to deliver vaccines directly to communities. This initiative aims to increase vaccination rates and contribute to ending the pandemic, as emphasized by COO Jim Peters.
Rite Aid (NYSE: RAD) has commenced administering the COVID-19 vaccine across its 2,500 stores in 17 states, following federal guidance allowing those aged 16 and older to get vaccinated. The company promotes appointment scheduling while also offering limited walk-in vaccinations to cater to individuals without internet access. Rite Aid's pharmacists are prepared to administer the Moderna, Pfizer-BioNTech, and Johnson & Johnson vaccines, enhancing community health efforts. For more details, visit www.RiteAid.com/covid-19.
